Activity profiles of two hyperforin-containing Hypericum extracts in behavioral models

被引:101
作者
Bhattacharya, SK
Chakrabarti, A
Chatterjee, SS
机构
[1] Dr Willmar Schwabe Gmbh & Co, Dept Pharmacol, D-76227 Karlsruhe, Germany
[2] Banaras Hindu Univ, Inst Med Sci, Dept Pharmacol, Varanasi 221005, Uttar Pradesh, India
关键词
D O I
10.1055/s-2007-979342
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The behavioral activity profile of a therapeutically used alholic hypericum extract containing hyperforin (4.5%) in rodent models was compared with that of an experimental CO(2) extract devoid of hypericines but highly enriched in hyperforin (38.8%). The antidepressant activities of 50, 150 and 300 mg/kg/day of the alcoholic extract were similar to those of 5, 15 and 30 mg/kg/day respectively of the CO( 2)extract. The ethanol extract in the same dose range potentiated dopaminergic behavioral responses, whereas these effects were either absent or less pronounced in the CO(2) extract treated groups. By contrast, serotoninergic effects of the CO(2) extract were more pronounced than those of the alcoholic extract. These and various other observations made during the study confirm that although the antidepressant action of hypericum extracts depends on their hyperforin contents, their spectrums of central activity are due to other component(s). Our working hypothesis that hyperforin and serotoninergic mechanisms are involved in the therapeutically observed antidepressant activities of hypericum extracts is in agreement with these observations.
引用
收藏
页码:22 / 29
页数:8
相关论文
共 22 条
  • [1] EFFECTS OF MUSCARINIC RECEPTOR AGONISTS AND ANTAGONISTS ON DOPAMINE-MEDIATED BEHAVIORAL PARADIGMS
    BHATTACHARYA, SK
    SEN, AP
    [J]. JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1991, 84 (03) : 241 - 246
  • [2] Bombardelli Ezio, 1995, Fitoterapia, V66, P43
  • [3] Effects of the total extract and fractions of hypericum perforatum in animal assays for antidepressant activity
    Butterweck, V
    Wall, A
    LieflanderWulf, U
    Winterhoff, H
    Nahrstedt, A
    [J]. PHARMACOPSYCHIATRY, 1997, 30 : 117 - 124
  • [4] Antidepressant activity of Hypericum perforatum and hyperforin: The neglected possibility
    Chatterjee, SS
    Noldner, M
    Koch, E
    Erdelmeier, C
    [J]. PHARMACOPSYCHIATRY, 1998, 31 : 7 - 15
  • [5] CHATTERJEE SS, 1998, IN PRESS LIFE SCI
  • [6] CHATTERJEE SS, 1996, PHYTOMEDICINE S1, V3, P106
  • [7] In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract
    Cott, JM
    [J]. PHARMACOPSYCHIATRY, 1997, 30 : 108 - 112
  • [8] Ganguli Snigdha, 1996, Indian Journal of Experimental Biology, V34, P408
  • [9] HOLZL J, 1994, PHARM ZTG, V46, P3959
  • [10] HOROVTTZ Z. P., 1965, LIFE SCI, V4, P1909, DOI 10.1016/0024-3205(65)90075-5